A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells

BACKGROUND: Resistance to gefitinib remains a major obstacle for the successful treatment of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations. In this paper, we studied the precise actions of circular RNA (circRNA) microtubule actin crosslinking factor 1 (cir...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Daping, Yang, Yue, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742390/
https://www.ncbi.nlm.nih.gov/pubmed/34996416
http://dx.doi.org/10.1186/s12890-021-01731-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742390/
https://www.ncbi.nlm.nih.gov/pubmed/34996416
http://dx.doi.org/10.1186/s12890-021-01731-z

Ejemplares similares